Abstract
We report the development of functionalized superparamagnetic iron oxide nanoparticles with a PEG-modified, phospholipid micelle coating, and their delivery into living cells. The size of the coated particles, as determined by dynamic light scattering and electron microscopy, was found to be between 12 and 14 nm. The PEG-phospholipid coating resulted in high water solubility and stability, and the functional groups of modified PEG allowed for bioconjugation of various moieties, including a fluorescent dye and the Tat peptide. Efficient delivery of the functionalized nanoparticles into living cells was confirmed by fluorescence microscopy, relaxation time measurements, and magnetic resonance imaging (MRI). This demonstrates the feasibility of using functionalized magnetic nanoparticles with uniform (~10 nm) sizes as an MRI contrast agent for intracellular molecular imaging in deep tissue. These micelle-coated iron oxide nanoparticles offer a versatile platform for conjugation of a variety of moieties, and their small size confers advantages for intracellular molecular imaging with minimal perturbation.
Similar content being viewed by others
Abbreviations
- CPP:
-
cell penetrating peptide
- CPMG:
-
Carr–Purcell–Meiboom–Gill spin-echo method
- CTAB:
-
cetyltrimethylammonium bromide
- DLS:
-
dynamic light scattering
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- DSPE:
-
1,2-distearoyl-sn-glycero-3-phosphoethanolamine
- FCS:
-
fetal calf serum
- FGM-2:
-
fibroblast growth medium 2
- HDF:
-
human dermal fibroblast
- HS:
-
horse serum
- MDBK:
-
Madin–Darby bovine kidney
- MIONs:
-
superparamagnetic iron oxide nanoparticles
- mMIONs:
-
micelle-coated MIONs
- MRI:
-
magnetic resonance imaging
- PBS:
-
phosphate-buffered saline
- PEG:
-
poly(ethylene glycol)
- SPDP:
-
N-succinimidyl 3-(2-pyridyldithio)propionate
- TCEP:
-
tris(2-carboxyethyl)phosphine hydrochloride
- TEM:
-
transmission electron microscopy
References
Dyal A, Loos K, Noto M, Chang SW, Spagnoli C, et al. (2003) J Am Chem Soc 125:1684–1685
Zhao M, Kircher MF, Josephson L, Weissleder R (2002) Bioconjug Chem 13:840–844
Bulte JWM, Douglas T, Witwer B, Zhang S-C, Strable E, et al. (2001) Nat Biotechnol 19:1141–1147
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, et al. (2000) Nat Biotechnol 18:410–414
Dressman D, Yan H, Traverso G, Kinzler KW, Vogelstein B (2003) Proc Natl Acad Sci USA 100:8817–8822
Lanza GM, Abendschein DR, Yu X, Winter PM, Karukstis KK, et al. (2002) Acad Radiol (Suppl 2) 9:S330–S331
Butler JP, Kelly SM (1998) Biorheology 35:193–209
Perez JM, O’Loughin T, Simeone FJ, Weissleder R, Josephson L (2002) J Am Chem Soc 124:2856–2857
Liu Q, Xu Z (1995) Langmuir 12:4617–4622
Yee C, Kataby G, Ulman A, Prozorov T, White H, et al. (1999) Langmuir 15:7111–7115
Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, et al. (2003) Chem Mater 15:1367–1377
Burke NAD, Stover HDH, Dawson FP (2002) Chem Mater 14:4752–4761
Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W (2001) Langmuir 17:2900–2906
Lu Y, Yin Y, Mayers BT, Xia Y (2002) Nano Letters 2:183–186
Butterworth MD, Illum L, Davis SS (2001) Colloids Surf A 179:93–102
Kim DK, Mikhaylova M, Zhang Y, Muhammed M (2003) Chem Mater 15:1617–1627
Jones M, Leroux J (1999) Eur J Pharmacol Biopharmacol 48:101–111
Perkins WR, Ahmad I, Li X, Hirsh DJ, Masters GR, et al. (2000) Int J Pharmacol 200:27–39
Torchilin VP (2002) Adv Drug Deliv Rev 54:235–252
Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B (2003) Proc Natl Acad Sci USA 100:6039–6044
Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A (2002) Science 298:1759–1762
Gref R, Couvreur P, Barratt G, Mysiakine E (2003) Biomaterials 24:4529–4537
Braginskaya TG, Dobitchin PD, Ivanova MA, Klyubin VV, Lomakin AV, et al. (1983) Phys Scr 28:73–79
Atkins RC (1975) J Chem Educ 52:550
Feltin N, Pileni MP (1997) Langmuir 13:3927–3933
Seip CT, O’Connor CJ (1999) NanoStruct Mater 12:183–186
Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, D’Souza GG (2003) Proc Natl Acad Sci USA 100:1972–1977
Torchilin VP, Rammohan R, Weissig V, Levchenko TS (2001) Proc Natl Acad Sci USA 98:8786–8791
Haacke EM, Brown RW, Thompson MR, Venkatesan R (1999) Magnetic resonance imaging: physical principles and sequence design. Wiley, New York
Acknowledgements
The authors thank Dr. Charles O’Connor and his group (Daniela Carunta and Brian Cushing) for providing magnetic nanoparticles, Igor Vilfin and Nicholas Hud for their help with DLS measurements, and Hong Yi for her assistance with electron microscopy. This work was supported by DARPA/AFOSR (F49620–03–1-0320).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nitin, N., LaConte, L.E.W., Zurkiya, O. et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem 9, 706–712 (2004). https://doi.org/10.1007/s00775-004-0560-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-004-0560-1